-
1
-
-
26444472368
-
Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer
-
Aguiar S, Jr, Lopes A, Soares FA, Rossi BM, Ferreira FO, Nakagawa WT, Carvalho AL, David Filho WJ. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer. Eur J Surg Oncol 2005;31:863-8.
-
(2005)
Eur J Surg Oncol
, vol.31
, pp. 863-868
-
-
Aguiar Jr., S.1
Lopes, A.2
Soares, F.A.3
Rossi, B.M.4
Ferreira, F.O.5
Nakagawa, W.T.6
Carvalho, A.L.7
David Filho, W.J.8
-
2
-
-
0036812810
-
Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer
-
Sugiyama Y, Kato T, Nakazato H, Ito K, Mizuno I, Kanemitsu T, Matsumoto K, Yamaguchi A, Nakai K, Inada K, Tatematsu M. Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer. Anticancer Drugs 2002;13:931-8.
-
(2002)
Anticancer Drugs
, vol.13
, pp. 931-938
-
-
Sugiyama, Y.1
Kato, T.2
Nakazato, H.3
Ito, K.4
Mizuno, I.5
Kanemitsu, T.6
Matsumoto, K.7
Yamaguchi, A.8
Nakai, K.9
Inada, K.10
Tatematsu, M.11
-
3
-
-
0036534108
-
Thymidylate synthase expression in colorectal cancer: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy
-
Edler D, Glimelius B, Hallstrom M, Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 2002;20:1721-8.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1721-1728
-
-
Edler, D.1
Glimelius, B.2
Hallstrom, M.3
Jakobsen, A.4
Johnston, P.G.5
Magnusson, I.6
Ragnhammar, P.7
Blomgren, H.8
-
4
-
-
0035209477
-
Thymidylate synthase expression in stage II and III colon cancer: A retrospective review
-
Tomiak A, Vincent M, Earle CC, Johnston PG, Kocha W, Taylor M, Maroun J, Eidus L, Whiston F, Stitt L. Thymidylate synthase expression in stage II and III colon cancer: a retrospective review. Am J Clin Oncol 2001;24:597-602.
-
(2001)
Am J Clin Oncol
, vol.24
, pp. 597-602
-
-
Tomiak, A.1
Vincent, M.2
Earle, C.C.3
Johnston, P.G.4
Kocha, W.5
Taylor, M.6
Maroun, J.7
Eidus, L.8
Whiston, F.9
Stitt, L.10
-
5
-
-
0028151449
-
The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
-
Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12:2640-7.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2640-2647
-
-
Johnston, P.G.1
Fisher, E.R.2
Rockette, H.E.3
Fisher, B.4
Wolmark, N.5
Drake, J.C.6
Chabner, B.A.7
Allegra, C.J.8
-
6
-
-
9144264837
-
Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: Low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone
-
Tsuji T, Sawai T, Takeshita H, Nakagoe T, Hidaka S, Atsushi N, Yamaguchi H, Yasutake T, Nagayasu T, Tagawa Y. Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone. Cancer Lett 2004;204:97-104.
-
(2004)
Cancer Lett
, vol.204
, pp. 97-104
-
-
Tsuji, T.1
Sawai, T.2
Takeshita, H.3
Nakagoe, T.4
Hidaka, S.5
Atsushi, N.6
Yamaguchi, H.7
Yasutake, T.8
Nagayasu, T.9
Tagawa, Y.10
-
7
-
-
24944441382
-
Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information
-
Ohrling K, Edler D, Hallstrom M, Ragnhammar P, Blomgren H. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information. J Clin Oncol 2005;23:5628-34.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5628-5634
-
-
Ohrling, K.1
Edler, D.2
Hallstrom, M.3
Ragnhammar, P.4
Blomgren, H.5
-
8
-
-
33244468377
-
Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up
-
Lassmann S, Hennig M, Rosenberg R, Nahrig J, Schreglmann J, Krause F, Poignee-Heger M, Nekarda H, Hofler H, Werner M. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. Int J Colorectal Dis 2005;21:238-47.
-
(2005)
Int J Colorectal Dis
, vol.21
, pp. 238-247
-
-
Lassmann, S.1
Hennig, M.2
Rosenberg, R.3
Nahrig, J.4
Schreglmann, J.5
Krause, F.6
Poignee-Heger, M.7
Nekarda, H.8
Hofler, H.9
Werner, M.10
-
9
-
-
11144303556
-
Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer
-
Tsuji T, Sawai T, Takeshita H, Nakagoe T, Hidaka S, Yamaguchi H, Yasutake T, Nagayasu T, Tagawa Y. Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer. Cancer Chemother Pharmacol 2004;54:531-6.
-
(2004)
Cancer Chemother Pharmacol
, vol.54
, pp. 531-536
-
-
Tsuji, T.1
Sawai, T.2
Takeshita, H.3
Nakagoe, T.4
Hidaka, S.5
Yamaguchi, H.6
Yasutake, T.7
Nagayasu, T.8
Tagawa, Y.9
-
10
-
-
1442277085
-
Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer
-
Oi K, Makino M, Ozaki M, Takemoto H, Yamane N, Nakamura S, Ikeguchi M, Kaibara N. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer. Anticancer Res 2004;24:273-9.
-
(2004)
Anticancer Res
, vol.24
, pp. 273-279
-
-
Oi, K.1
Makino, M.2
Ozaki, M.3
Takemoto, H.4
Yamane, N.5
Nakamura, S.6
Ikeguchi, M.7
Kaibara, N.8
-
11
-
-
12444302837
-
Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer
-
Tsuji T, Hidaka S, Sawai T, Nakagoe T, Yano H, Haseba M, Komatsu H, Shindou H, Fukuoka H, Yoshinaga M, Shibasaki S, Nanashima A, et al. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer. Clin Cancer Res 2003;9:3700-4.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3700-3704
-
-
Tsuji, T.1
Hidaka, S.2
Sawai, T.3
Nakagoe, T.4
Yano, H.5
Haseba, M.6
Komatsu, H.7
Shindou, H.8
Fukuoka, H.9
Yoshinaga, M.10
Shibasaki, S.11
Nanashima, A.12
-
12
-
-
0141455146
-
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: Predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil
-
Kornmann M, Schwabe W, Sander S, Kron M, Strater J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Hausler P, Ott K, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res 2003;9:4116-24.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4116-4124
-
-
Kornmann, M.1
Schwabe, W.2
Sander, S.3
Kron, M.4
Strater, J.5
Polat, S.6
Kettner, E.7
Weiser, H.F.8
Baumann, W.9
Schramm, H.10
Hausler, P.11
Ott, K.12
-
13
-
-
0036534002
-
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer
-
Allegra CJ, Parr AL, Wold LE, Mahoney MR, Sargent DJ, Johnston P, Klein P, Behan K, O'Connell MJ, Levitt R, Kugler JW, Tria TM, et al. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol 2002;20:1735-43.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1735-1743
-
-
Allegra, C.J.1
Parr, A.L.2
Wold, L.E.3
Mahoney, M.R.4
Sargent, D.J.5
Johnston, P.6
Klein, P.7
Behan, K.8
O'Connell, M.J.9
Levitt, R.10
Kugler, J.W.11
Tria, T.M.12
-
14
-
-
0036582566
-
Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy
-
Nishimura G, Terada I, Kobayashi T, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Kayahara M, Shimizu K, Ohta T, Miwa K. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5′-deoxy-5-fluorouridine as adjuvant chemotherapy. Oncol Rep 2002;9:479-82.
-
(2002)
Oncol Rep
, vol.9
, pp. 479-482
-
-
Nishimura, G.1
Terada, I.2
Kobayashi, T.3
Ninomiya, I.4
Kitagawa, H.5
Fushida, S.6
Fujimura, T.7
Kayahara, M.8
Shimizu, K.9
Ohta, T.10
Miwa, K.11
-
15
-
-
0033995850
-
Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method
-
Takenoue T, Nagawa H, Matsuda K, Fujii S, Nita ME, Hatano K, Kitayama J, Tsuruo T, Muto T. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 2000;7:193-8.
-
(2000)
Ann Surg Oncol
, vol.7
, pp. 193-198
-
-
Takenoue, T.1
Nagawa, H.2
Matsuda, K.3
Fujii, S.4
Nita, M.E.5
Hatano, K.6
Kitayama, J.7
Tsuruo, T.8
Muto, T.9
-
16
-
-
0037862137
-
Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: Immunohistochemistry using a new monoclonal antibody
-
Tokunaga Y, Nakagami M, Tokuka A, Ohsumi K. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody. Anticancer Res 2003;23:1763-8.
-
(2003)
Anticancer Res
, vol.23
, pp. 1763-1768
-
-
Tokunaga, Y.1
Nakagami, M.2
Tokuka, A.3
Ohsumi, K.4
-
17
-
-
0036942196
-
Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis
-
Ikeguchi M, Makino M, Kaibara N. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis. Langenbecks Arch Surg 2002;387:240-5.
-
(2002)
Langenbecks Arch Surg
, vol.387
, pp. 240-245
-
-
Ikeguchi, M.1
Makino, M.2
Kaibara, N.3
-
18
-
-
27144456276
-
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
-
Westra JL, Hollema H, Schaapveld M, Platteel I, Oien KA, Keith WN, Mauritz R, Peters GJ, Buys CH, Hofstra RM, Plukker JT. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients. Ann Oncol 2005;16:1646-53.
-
(2005)
Ann Oncol
, vol.16
, pp. 1646-1653
-
-
Westra, J.L.1
Hollema, H.2
Schaapveld, M.3
Platteel, I.4
Oien, K.A.5
Keith, W.N.6
Mauritz, R.7
Peters, G.J.8
Buys, C.H.9
Hofstra, R.M.10
Plukker, J.T.11
-
19
-
-
0035860142
-
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
-
Iacopetta B, Grieu F, Joseph D, Elsaleh H. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 2001;85:827-30.
-
(2001)
Br J Cancer
, vol.85
, pp. 827-830
-
-
Iacopetta, B.1
Grieu, F.2
Joseph, D.3
Elsaleh, H.4
-
20
-
-
0035868667
-
Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer
-
Villafranca E, Okruzhnov Y, Dominguez, MA, Garcia-Foncillas J, Azinovic I, Martinez E, Illarramendi JJ, Arias F, Martinez MR, Salgado E, Angeletti S, Brugarolas A. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J Clin Oncol 2001;19:1779-86.
-
(2001)
J Clin Oncol
, vol.19
, pp. 1779-1786
-
-
Villafranca, E.1
Okruzhnov, Y.2
Dominguez, M.A.3
Garcia-Foncillas, J.4
Azinovic, I.5
Martinez, E.6
Illarramendi, J.J.7
Arias, F.8
Martinez, M.R.9
Salgado, E.10
Angeletti, S.11
Brugarolas, A.12
-
21
-
-
1442290323
-
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
-
Popat S, Matakidou A, Houlston RS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2004;22:529-36.
-
(2004)
J Clin Oncol
, vol.22
, pp. 529-536
-
-
Popat, S.1
Matakidou, A.2
Houlston, R.S.3
-
22
-
-
10944243586
-
Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil
-
Hosokawa A, Yamada Y, Shimada Y, Muro K, Hamaguchi T, Morita H, Araake M, Orita H, Shirao K. Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil. Int J Clin Oncol 2004;9:388-92.
-
(2004)
Int J Clin Oncol
, vol.9
, pp. 388-392
-
-
Hosokawa, A.1
Yamada, Y.2
Shimada, Y.3
Muro, K.4
Hamaguchi, T.5
Morita, H.6
Araake, M.7
Orita, H.8
Shirao, K.9
-
23
-
-
0036928518
-
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil
-
Aschele C, Debernardis D, Bandelloni R, Cascinu S, Catalano V, Giordani P, Barni S, Turci D, Drudi G, Lonardi S, Gallo L, Maley F, et al. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil. Ann Oncol 2002;13:1882-92.
-
(2002)
Ann Oncol
, vol.13
, pp. 1882-1892
-
-
Aschele, C.1
Debernardis, D.2
Bandelloni, R.3
Cascinu, S.4
Catalano, V.5
Giordani, P.6
Barni, S.7
Turci, D.8
Drudi, G.9
Lonardi, S.10
Gallo, L.11
Maley, F.12
-
24
-
-
0033637476
-
Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma
-
Tachikawa D, Arima S, Futami K. Immunohistochemical expression of thymidylate synthase as a prognostic factor and as a chemotherapeutic efficacy index in patients with colorectal carcinoma. Anticancer Res 2000;20:4103-7.
-
(2000)
Anticancer Res
, vol.20
, pp. 4103-4107
-
-
Tachikawa, D.1
Arima, S.2
Futami, K.3
-
25
-
-
0033975032
-
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
-
Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ, Johnston PG. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 2000;82:560-7.
-
(2000)
Br J Cancer
, vol.82
, pp. 560-567
-
-
Paradiso, A.1
Simone, G.2
Petroni, S.3
Leone, B.4
Vallejo, C.5
Lacava, J.6
Romero, A.7
Machiavelli, M.8
De Lena, M.9
Allegra, C.J.10
Johnston, P.G.11
-
26
-
-
0032997572
-
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy
-
Aschele C, Debernardis D, Casazza S, Antonelli G, Tunesi G, Baldo C, Lionetto R, Maley F, Sobrero A. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol 1999;17:1760-70.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1760-1770
-
-
Aschele, C.1
Debernardis, D.2
Casazza, S.3
Antonelli, G.4
Tunesi, G.5
Baldo, C.6
Lionetto, R.7
Maley, F.8
Sobrero, A.9
-
27
-
-
0035576102
-
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
-
Shirota Y, Stoehlmacher J, Brabender J, Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg PV, Lenz HJ. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol 2001;19:4298-304.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4298-4304
-
-
Shirota, Y.1
Stoehlmacher, J.2
Brabender, J.3
Xiong, Y.P.4
Uetake, H.5
Danenberg, K.D.6
Groshen, S.7
Tsao-Wei, D.D.8
Danenberg, P.V.9
Lenz, H.J.10
-
28
-
-
7244258790
-
Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients
-
Marcuello E, Altes A, del Rio E, Cesar A, Menoyo A, Baiget M. Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004;112:733-7.
-
(2004)
Int J Cancer
, vol.112
, pp. 733-737
-
-
Marcuello, E.1
Altes, A.2
Del Rio, E.3
Cesar, A.4
Menoyo, A.5
Baiget, M.6
-
29
-
-
3843130823
-
A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
-
Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004;91:344-54.
-
(2004)
Br J Cancer
, vol.91
, pp. 344-354
-
-
Stoehlmacher, J.1
Park, D.J.2
Zhang, W.3
Yang, D.4
Groshen, S.5
Zahedy, S.6
Lenz, H.J.7
-
30
-
-
0035750549
-
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy
-
Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, Warren R, Tsao-Wei D, Groshen S, Lenz HJ. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J 2001;1:65-70.
-
(2001)
Pharmacogenomics J
, vol.1
, pp. 65-70
-
-
Pullarkat, S.T.1
Stoehlmacher, J.2
Ghaderi, V.3
Xiong, Y.P.4
Ingles, S.A.5
Sherrod, A.6
Warren, R.7
Tsao-Wei, D.8
Groshen, S.9
Lenz, H.J.10
-
31
-
-
0037096901
-
Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: Phenotypic and genotypic analyses
-
Etienne MC, Chazal M, Laurent-Puig P, Magne N, Rosty C, Formento JL, Francoual M, Formento P, Renee N, Chamorey E, Bourgeon A, Seitz JF, et al. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol 2002;20:2832-43.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2832-2843
-
-
Etienne, M.C.1
Chazal, M.2
Laurent-Puig, P.3
Magne, N.4
Rosty, C.5
Formento, J.L.6
Francoual, M.7
Formento, P.8
Renee, N.9
Chamorey, E.10
Bourgeon, A.11
Seitz, J.F.12
-
32
-
-
3142660249
-
Topoisomerase-1, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients
-
Paradiso A, Xu J, Mangia A, Chiriatti A, Simone G, Zito A, Montemurro S, Giuliani F, Maiello E, Colucci G. Topoisomerase-1, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004;111:252-8.
-
(2004)
Int J Cancer
, vol.111
, pp. 252-258
-
-
Paradiso, A.1
Xu, J.2
Mangia, A.3
Chiriatti, A.4
Simone, G.5
Zito, A.6
Montemurro, S.7
Giuliani, F.8
Maiello, E.9
Colucci, G.10
-
33
-
-
0037364351
-
Thymidylate synthase protein expression in primary colorectal cancer: Lack of correlation with outcome and response to fluorouracil in metastatic disease sites
-
Johnston PG, Benson AB, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol 2003;21:815-19.
-
(2003)
J Clin Oncol
, vol.21
, pp. 815-819
-
-
Johnston, P.G.1
Benson, A.B.2
Catalano, P.3
Rao, M.S.4
O'Dwyer, P.J.5
Allegra, C.J.6
-
34
-
-
0036875104
-
Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma
-
Berglund A, Edler D, Molin D, Nordlinder H, Graf W, Glimelius B. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma. Anticancer Res 2002;22:3653-9.
-
(2002)
Anticancer Res
, vol.22
, pp. 3653-3659
-
-
Berglund, A.1
Edler, D.2
Molin, D.3
Nordlinder, H.4
Graf, W.5
Glimelius, B.6
-
35
-
-
0031053520
-
Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy
-
Findlay MP, Cunningham D, Morgan G, Clinton S, Hardcastle A, Aherne GW. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. Br J Cancer 1997;75:903-9.
-
(1997)
Br J Cancer
, vol.75
, pp. 903-909
-
-
Findlay, M.P.1
Cunningham, D.2
Morgan, G.3
Clinton, S.4
Hardcastle, A.5
Aherne, G.W.6
-
36
-
-
0035344101
-
Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine
-
Ikeguchi M, Hirooka Y, Makino M, Kaibara N. Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine. Oncol Rep 2001;8:621-5.
-
(2001)
Oncol Rep
, vol.8
, pp. 621-625
-
-
Ikeguchi, M.1
Hirooka, Y.2
Makino, M.3
Kaibara, N.4
-
37
-
-
2142745873
-
Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: Association with survival
-
Tanaka-Nozaki M, Tajiri T, Tanaka N, Furukawa K, Takasaki H, Yoshimura K, Suzuki H, Naito Z, Sugizaki Y, Merk HF, Blomeke B, Kato S. Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival. Oncol Rep 2003;10:1425-9.
-
(2003)
Oncol Rep
, vol.10
, pp. 1425-1429
-
-
Tanaka-Nozaki, M.1
Tajiri, T.2
Tanaka, N.3
Furukawa, K.4
Takasaki, H.5
Yoshimura, K.6
Suzuki, H.7
Naito, Z.8
Sugizaki, Y.9
Merk, H.F.10
Blomeke, B.11
Kato, S.12
-
38
-
-
0037440051
-
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: A National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study
-
Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N. Wicand HS. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003;21:241-50.
-
(2003)
J Clin Oncol
, vol.21
, pp. 241-250
-
-
Allegra, C.J.1
Paik, S.2
Colangelo, L.H.3
Parr, A.L.4
Kirsch, I.5
Kim, G.6
Klein, P.7
Johnston, P.G.8
Wolmark, N.9
Wicand, H.S.10
-
39
-
-
0036188129
-
Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer
-
Corsi DC, Ciaparrone M, Zannoni G, Malicini M, Cassano A, Specchia M, Pozzo C, Martini M, Barone C. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer. Eur J Cancer 2002;38:527-34.
-
(2002)
Eur J Cancer
, vol.38
, pp. 527-534
-
-
Corsi, D.C.1
Ciaparrone, M.2
Zannoni, G.3
Malicini, M.4
Cassano, A.5
Specchia, M.6
Pozzo, C.7
Martini, M.8
Barone, C.9
-
40
-
-
0035555656
-
Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
-
Wong NA, Brett L, Stewart M, Leitch A, Longley DB, Dunlop MG, Johnston PG, Lessells AM, Jodrell DI. Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Br J Cancer 2001;85:1937-43.
-
(2001)
Br J Cancer
, vol.85
, pp. 1937-1943
-
-
Wong, N.A.1
Brett, L.2
Stewart, M.3
Leitch, A.4
Longley, D.B.5
Dunlop, M.G.6
Johnston, P.G.7
Lessells, A.M.8
Jodrell, D.I.9
-
41
-
-
0034486207
-
Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil
-
Aschele C, Debernardis D, Tunesi G, Maley F, Sobrero A. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil. Clin Cancer Res 2000;6:4797-802.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4797-4802
-
-
Aschele, C.1
Debernardis, D.2
Tunesi, G.3
Maley, F.4
Sobrero, A.5
-
42
-
-
0035430619
-
Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion
-
Uchida K, Hayashi K, Kuramochi H, Takasaki K. Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion. Int J Oncol 2001;19:341-6.
-
(2001)
Int J Oncol
, vol.19
, pp. 341-346
-
-
Uchida, K.1
Hayashi, K.2
Kuramochi, H.3
Takasaki, K.4
-
43
-
-
14944380124
-
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity
-
Jakobsen A, Nielsen JN, Gyldenkerne N, Lindeberg J. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. J Clin Oncol 2005;23:1365-9.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1365-1369
-
-
Jakobsen, A.1
Nielsen, J.N.2
Gyldenkerne, N.3
Lindeberg, J.4
-
44
-
-
0037144354
-
Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: High prevalence of the IVS14+1g>a mutation
-
van Kuilenburg AB, Meinsma R, Zoetekouw L, van Gennip AH. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation. Int J Cancer 2002;101:253-8.
-
(2002)
Int J Cancer
, vol.101
, pp. 253-258
-
-
Van Kuilenburg, A.B.1
Meinsma, R.2
Zoetekouw, L.3
Van Gennip, A.H.4
-
45
-
-
9744250225
-
Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer
-
Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Hausler P, Becker H, Liersch T. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. J Pathol 2004;204:562-8.
-
(2004)
J Pathol
, vol.204
, pp. 562-568
-
-
Jakob, C.1
Aust, D.E.2
Meyer, W.3
Baretton, G.B.4
Schwabe, W.5
Hausler, P.6
Becker, H.7
Liersch, T.8
-
46
-
-
8344245563
-
Thymidylate synthase expression in normal colonic mucosa: A predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy
-
Santini D, Vincenzi B, Perrone G, Rabitti C, Borzomati D, Caricato M, La Cesa A, Grilli C, Verzi A, Coppola R, Tonini G. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy. Oncology 2004;67:135-42.
-
(2004)
Oncology
, vol.67
, pp. 135-142
-
-
Santini, D.1
Vincenzi, B.2
Perrone, G.3
Rabitti, C.4
Borzomati, D.5
Caricato, M.6
La Cesa, A.7
Grilli, C.8
Verzi, A.9
Coppola, R.10
Tonini, G.11
-
47
-
-
0036892789
-
Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients
-
Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M, Saito K. Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. Eur J Cancer 2002;38:2375-81.
-
(2002)
Eur J Cancer
, vol.38
, pp. 2375-2381
-
-
Terashima, M.1
Fujiwara, H.2
Takagane, A.3
Abe, K.4
Araya, M.5
Irinoda, T.6
Yonezawa, H.7
Nakaya, T.8
Oyama, K.9
Takahashi, M.10
Saito, K.11
|